The Hidden Dangers Facing UnitedHealth Stock

+11.43%
Upside
341
Market
380
Trefis
UNH: UnitedHealth logo
UNH
UnitedHealth

UnitedHealth (UNH) has stumbled before. Its stock has plunged more than 30% within a span of less than 2 months on 2 occasions in recent years, wiping out billions in market value, and erasing massive gains in a single correction. If history is any guide, UNH stock isn’t immune to sudden, sharp declines.

UnitedHealth, once a bedrock of stability, has seen its stock slide by nearly half over the past year, battered by unexpectedly soaring Medicare Advantage costs and an intensifying Department of Justice probe into its billing practices. This dramatic downturn underscores how even a healthcare behemoth, despite recent fleeting upticks, remains acutely vulnerable to unforeseen medical trend shifts and the ever-tightening grip of regulatory scrutiny.

What Could Send The Stock Crashing?

  • Regulatory Scrutiny: Ongoing DOJ criminal and civil investigations into Medicare Advantage billing, antitrust probes into Optum’s vertical integration, and proposed legislation targeting PBMs risk substantial fines, forced divestitures, and fundamental business model changes.
  • Rising Medical Costs: Higher-than-expected care utilization, particularly in Medicare Advantage and Optum Health, is pressuring profit margins, evidenced by the 600 basis point increase in MCR to ~88% by late 2025 and reduced 2025 EPS guidance to $16.25.
  • Cyberattack Fallout: The February 2024 Change Healthcare ransomware attack, impacting 190 million Americans, continues to pose a threat through lingering financial costs (over $3 billion in 2024), reputational damage, and ongoing need for significant cybersecurity investments.

Relevant Articles
  1. The Next Big Rally in UnitedHealth Stock Could Start Like This
  2. UnitedHealth Stock Capital Return Hits $78 Bil
  3. How Does MCR Impact UnitedHealth’s Earnings And Stock?
  4. Buy or Sell UnitedHealth Stock?
  5. Buy or Sell UnitedHealth Stock?
  6. Buy or Sell UnitedHealth Stock?

What’s The Worst That Could Happen?

Looking at UNH’s history during market downturns gives a clear picture of its risk profile. It fell about 72% during the Global Financial Crisis, the biggest drop on record. The Dot-Com crash saw a roughly 42% pullback, and even in more recent episodes—like the Covid sell-off and 2018 correction—it took hits of around 36% and 24%, respectively. The inflation shock caused a smaller dip of about 18%, but that’s still notable. So while UNH checks a lot of quality boxes, sharp sell-offs still hit it hard when the broader market turns south.

But the risk is not limited to major market crashes. Stocks fall even when markets are good – think events like earnings, business updates, and outlook changes. Read UNH Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.

Is Risk Showing Up In The Company’s Financials Yet?

Let’s take a look at fundamentals

  • Revenue Growth: 10.5% LTM and 11.4% last 3-year average.
  • Cash Generation: Nearly 4.0% free cash flow margin and 6.1% operating margin LTM.
  • Valuation: UnitedHealth stock trades at a P/E multiple of 16.4

  UNH S&P Median
Sector Health Care
Industry Managed Health Care
PE Ratio 16.4 23.1

   
LTM* Revenue Growth 10.5% 6.1%
3Y Average Annual Revenue Growth 11.4% 5.4%

   
LTM* Operating Margin 6.1% 18.8%
3Y Average Operating Margin 7.7% 18.2%
LTM* Free Cash Flow Margin 4.0% 13.5%

*LTM: Last Twelve Months

If you want more details, read Buy or Sell UNH Stock.

Why Stock Pickers Win More With Multi Asset Portfolios

Single markets are unpredictable but different assets react differently. A multi asset portfolio cuts downside shocks while keeping upside on the table.

The asset allocation framework of Trefis’ Boston-based, wealth management partner yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Our partner’ strategy now includes Trefis High Quality Portfolio, which has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices